Soleno Therapeutics, Inc. announced that it will receive $59,988,250 in funding on October 2, 2023. The company will issue convertible preferred shares and option, warrant or other right to acquire another security in the transaction. The company will issue securities pursuant to exemption provided under Regulation D.